Regina DelBaugh, DO
Co-Associate Director of Transfusion Medicine and Apheresis; Assistant Professor
Department: Pathology
Phone: (804) 628-2576
Email: regina.delbaugh@vcuhealth.org
Regina DelBaugh, DO, is the Co-Associate Director of Transfusion Medicine and Apheresis. She is an assistant professor of pathology. She earned a Master of Science in Biomedical Sciences and Doctor of Osteopathic Medicine from the Philadelphia College of Osteopathic Medicine. She completed her residency in Anatomic and Clinical Pathology and Fellowship in Transfusion Medicine at Dartmouth Health in Lebanon, New Hampshire.
Contact Dr. DelBaugh for a full CV
Print/Download Dr. DelBaugh Web CV (pdf)
Dr. Regina DelBaugh abbreviated CV
Education
Postgraduate Medical Training
2023 - 2024 Fellowship, Transfusion Medicine, Dartmouth Health, Lebanon, NH
2019 - 2023 Residency, Anatomic and Clinical Pathology, Dartmouth Health, Lebanon, NH
Medical Education
2019 D.O. Philadelphia College of Osteopathic Medicine, Philadelphia, PA
Graduate Education
2013 M.S. Philadelphia College of Osteopathic Medicine, Philadelphia, PA
Undergraduate Education
2011 B.S. Saint Joseph’s University, Philadelphia, PA
Licenses & Certifications
Virginia Medical License
Blood Banking/Transfusion Medicine, American Board of Pathology
Anatomic and Clinical Pathology, American Board of Pathology
Selected Awards & Honors
Martha and Michael J. Avallone Endowed Memorial Scholarship
Philadelphia College of Osteopathic Medicine Alumni Scholarship
Philadelphia College of Osteopathic Medicine Foundation Scholarship
Philadelphia College of Osteopathic Medicine Board of Trustees Scholarship
Saint Joseph’s University Presidential Scholarship
Professional Service (outside)
2025 - present Cell Therapy Subcommittee, Clinical Applications Committee, Committee Member American Society for Apheresis (ASFA)
2025 - present Clinical Applications Committee, Committee Member American Society for Apheresis (ASFA)
2024 - present Donor Health and Safety Committee, Association for the Advancement of Blood and Biotherapies (AABB)
Selected Publications
Peer Reviewed Papers
DelBaugh RM, Murphy MF, Staves J, Fachini RM, Wendel S, Hands K, Bonet-Bub C, Kutner JM, Cohn CS, Cox CA, Jacquot C, Hasan RA, Lu W, Juskewitch JE, Raval JS, Rollins-Raval MA, Fung MK, Ziman A, Fermon EJ, Gorlin JB, Peters J, Dunbar NM; BEST foRmation of Anti‐D After Rhogam (RADAR) Study Investigators and the Biomedical Excellence for Safer Transfusion (BEST) Collaborative. Why do people still make anti-D over 50 years after the introduction of Rho(D) immune globulin? A Biomedical Excellence for Safer Transfusion (BEST) Collaborative study. Transfusion. 2025 May;65(5):957-967. doi: 10.1111/trf.18202. Epub 2025 Mar 10. PMID: 40059673.
DelBaugh RM, Thomas B, Gower BJ, Condict B, Luitel A, Davis KN, Szczepiorkowski ZM, Kaufman RM, Dunbar NM. Double trouble: A baby with concurrent hemolytic disease of the fetus and newborn and neonatal alloimmune thrombocytopenia. Transfusion. 2025 Jan 4. doi: 10.1111/trf.18120. Epub ahead of print. PMID: 39754478.
DelBaugh RM, Kerr DA, Dominguez-Konicki L, et al. Metastatic Neuroendocrine Neoplasms to the Pancreas: Two Unusual Cases and a Review of the Literature. International Journal of Surgical Pathology. 2023;0(0). doi:10.1177/10668969231185067
Toland, Maris MD; Bentz, Jessica MD; Bonasia, Kyra MD; Damiano, Ella MD; DelBaugh, Regina DO; Gerjevic, Kristen MD. Uterine and Ovarian Histopathology in Transmasculine and Nonbinary Patients on Testosterone Compared to Cisgender Control Patients [ID: 1381367]. Obstetrics & Gynecology 141(5S):p 5S, 2023. DOI: 10.1097/01.AOG.0000929752.88321.bf
DelBaugh RM, Cook LJ, Siegel CA, Tsongalis GJ, Khan WA. Validation of a rapid HLA-DQA1*05 pharmacogenomics assay to identify at-risk resistance to anti-tumor necrosis factor therapy among patients with inflammatory bowel disease. American Journal of Clinical Pathology 2023. https://doi.org/10.1093/ajcp/aqad036.
Toland MK, Bonasia K, Bentz J, DelBaugh RM, Vitale EJ, Scudder PN, Damiano EA. Uterine and Ovarian Histopathology after Testosterone for Gender Affirmation: A Systematic Review. Transgender Health 2023. https://doi.org/10.1089/trgh.2022.0207.
Ondrasik RM, Khan J, Szczepiorkowski ZM, Levy JJ, Dunbar NM. Passive order auditing associated with reductions in red blood cell utilization: National blood shortage experience. Transfusion. 2022;62(8):1551–8. https://doi.org/10.1111/trf.17008.
Anderson B, Ondrasik R, Kaur P. Alder-Reilly Anomaly: Morphologic Clue in a Patient with Hunter Syndrome. American Society of Hematology (ASH) Image Bank. Category: Myeloid Disorders > Lysosomal storage disorders. Published Date: 04/20/2022.
Ondrasik RM, Creed C, Anderson SR, Green DC, Houde BE, Godwin KN, Vaickus LJ, Lefferts JA, Khan WA, Tsongalis GJ. Validation of a Rapid PCR-based Assay for BRAF V600 Status for Prognostication and Therapeutic Selection in Colorectal Cancer Patients. J Molec Diagn 2021;23, 1620 (ST24).
Ondrasik RM, Cook LJ, Siegel CA, Tsongalis GJ, Khan WA. Validation of a Rapid HLA-DQA1*05 Pharmacogenomics Assay to Identify At-Risk Resistance to Anti-TNF Therapy in Inflammatory Bowel Disease (IBD) Patients. J Molec Diagn 2021;23, 1572 (G17).
Print/Download Dr. DelBaugh Web CV (pdf)